Jounce Therapeutics
JNCE
Delayed Nasdaq - 02/21 10:00:00 pm
23.56USD
+5.08%
Upcoming events

- No events available -

Past Events
01/10/18 | 11:30pmJ.P. Morgan Health Care Conference - Q&A
01/10/18 | 11:00pmJ.P. Morgan Health Care Conference
12/14/17 | 10:30pmBMO Capital Markets Prescriptions for Success Healthcare Conference
11/14/17 | 02:00pmStifel Nicolaus Health Care Conference
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
37,2
32,7
14%

75,5
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-12,5
-20,0
37%

-15,0
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-14,5
-17,7
18%

-26,3
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-13,7
-18,7
27%

-24,0
Net income
Million $
Released
Forecast
Spread
-23,1
-21,7
-6,7%

-26,7
EPS
 $
Released
Forecast
Spread
-11,0
-1,87
-490%

-0,65
Announcement Date03/10/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
18,1
20,0
-9,6%

16,2
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-3,48
-7,00
50%

-8,00
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-4,39
-8,95
51%

-18,8
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-3,67
-4,44
17%

-18,2
Net income
Million $
Released
Forecast
Spread
-4,08
-8,88
54%

-19,0
EPS
 $
Released
Forecast
Spread
-0,13
-0,25
48%

-0,37
Announcement Date11/13/2017